LPA

Summary

Gene Symbol: LPA
Description: lipoprotein, Lp(a)
Alias: AK38, APOA, antiangiogenic AK38 protein, apo(a), apolipoprotein(a), lp(a)
Species: human

Top Publications

  1. ncbi Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians
    Matthew B Lanktree
    Department of Medicine and Biochemistry, Robarts Research Institute and Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
    Circ Cardiovasc Genet 3:39-46. 2010
  2. ncbi Genetically elevated lipoprotein(a) and increased risk of myocardial infarction
    Pia R Kamstrup
    Department of Clinical Biochemistry, Herlev Hospital, Herlev Ringvej 75, DK 2730 Herlev, Denmark
    JAMA 301:2331-9. 2009
  3. ncbi Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study
    Pia R Kamstrup
    Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark
    Circulation 117:176-84. 2008
  4. ncbi cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
    J W McLean
    Department of Cardiovascular Research, Genentech, Inc, South San Francisco, California 94080
    Nature 330:132-7. 1987
  5. ncbi Molecular variation at functional genes and the history of human populations--data on candidate genes for cardiovascular risk in the Mediterranean
    Pedro Moral
    Department of Animal Biology Anthropology, University of Barcelona, Barcelona, Spain
    Coll Antropol 27:523-36. 2003
  6. ncbi A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease
    May M Luke
    Celera, 1401 Harbor Bay Parkway, Alameda, CA 94502, USA
    Arterioscler Thromb Vasc Biol 27:2030-6. 2007
  7. ncbi Apolipoprotein molecular variation in Moroccan Berbers: pentanucleotide (TTTTA)n repeat in the LPA gene and APOE-C1-C2 gene cluster
    N Harich
    Departement de Biologie, Faculte des Sciences, Université Chouaib Doukkali, El Jadida, Morocco, Spain
    Clin Genet 62:240-4. 2002
  8. ncbi APO(a) variants and lipoprotein(a) in men with or without myocardial infarction
    Guglielmina Chimienti
    Department of Biochemistry and Molecular Biology CSMME CNR, University of Bari, Italy
    Exp Mol Pathol 73:28-34. 2002
  9. ncbi The mysteries of lipoprotein(a)
    G Utermann
    Institute for Medical Biology and Genetics, University of Innsbruck, Austria
    Science 246:904-10. 1989
  10. ncbi Type of diabetes and waist-hip ratio are important determinants of serum lipoprotein (a) levels in diabetic patients
    Hapizah M Nawawi
    Chemical Pathology Unit, Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Cheras, 56000, Kuala Lumpur, Malaysia
    Diabetes Res Clin Pract 56:221-7. 2002

Research Grants

  1. Apolipoprotein-mediated cholesterol efflux
    W Davidson; Fiscal Year: 2007
  2. Apo E mimetics reduce cholesterol and improve HDL function
    G M Anantharamaiah; Fiscal Year: 2010
  3. Structure of apolipoprotein A-I on defined states of HDL
    MICHAEL NOBUAKI ODA; Fiscal Year: 2010
  4. Asthma Increases Vaso-occlusion in Sickle Cell Disease
    KIRKWOOD A contact PRITCHARD; Fiscal Year: 2010
  5. Dynamics of LCAT activation and lipoprotein remodeling
    Jere P Segrest; Fiscal Year: 2011
  6. HIGH DENSITY LIPOROTEIN STRUCTURE-FUNCTION CORRELATIONS
    Ana Jonas; Fiscal Year: 2001
  7. SR-BI: INFLUENCE OF APOA-II
    DENEYS VAN DER WESTHUYZEN; Fiscal Year: 2003
  8. Atherogenic Effects of Tyrosine Oxidation in HDL
    John Oram; Fiscal Year: 2004
  9. Apolipoprotein A-I structure in high density lipoproteins
    W Davidson; Fiscal Year: 2007
  10. Apolipoprotein A-I structure in high density lipoproteins
    W Sean Davidson; Fiscal Year: 2010

Detail Information

Publications191 found, 100 shown here

  1. ncbi Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians
    Matthew B Lanktree
    Department of Medicine and Biochemistry, Robarts Research Institute and Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
    Circ Cardiovasc Genet 3:39-46. 2010
    Functional copy number variation in the apolipoprotein(a) gene (LPA) underlies a variable number of protein kringle domains repeated in tandem in the lipoprotein(a) [Lp(a)] particle...
  2. ncbi Genetically elevated lipoprotein(a) and increased risk of myocardial infarction
    Pia R Kamstrup
    Department of Clinical Biochemistry, Herlev Hospital, Herlev Ringvej 75, DK 2730 Herlev, Denmark
    JAMA 301:2331-9. 2009
    ..High levels of lipoprotein(a) are associated with increased risk of myocardial infarction (MI)...
  3. ncbi Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study
    Pia R Kamstrup
    Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark
    Circulation 117:176-84. 2008
    ....
  4. ncbi cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
    J W McLean
    Department of Cardiovascular Research, Genentech, Inc, South San Francisco, California 94080
    Nature 330:132-7. 1987
    ..It contains a serine protease domain and two types of plasminogen-like kringle domains, one of which is present in 37 copies...
  5. ncbi Molecular variation at functional genes and the history of human populations--data on candidate genes for cardiovascular risk in the Mediterranean
    Pedro Moral
    Department of Animal Biology Anthropology, University of Barcelona, Barcelona, Spain
    Coll Antropol 27:523-36. 2003
    ..genes for cardiovascular disease including apolipopoteins and their receptors (APOA1, APOB, APOE, APOC1, APOC2, LPA, and LDLR), genes implied in the hemostasis regulation (Factor VII, alpha and beta-fibrinogen, alpha and beta ..
  6. ncbi A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease
    May M Luke
    Celera, 1401 Harbor Bay Parkway, Alameda, CA 94502, USA
    Arterioscler Thromb Vasc Biol 27:2030-6. 2007
    ..The purpose of this study was to identify genetic variants associated with severe coronary artery disease (CAD)...
  7. ncbi Apolipoprotein molecular variation in Moroccan Berbers: pentanucleotide (TTTTA)n repeat in the LPA gene and APOE-C1-C2 gene cluster
    N Harich
    Departement de Biologie, Faculte des Sciences, Université Chouaib Doukkali, El Jadida, Morocco, Spain
    Clin Genet 62:240-4. 2002
    Apolipoprotein LPA, APOE, APOC1, and APOC2 genotype frequencies have been determined for the first time in a North African population. A sample of 140 Berber individuals from the Moroccan Moyen Atlas region has been analyzed...
  8. ncbi APO(a) variants and lipoprotein(a) in men with or without myocardial infarction
    Guglielmina Chimienti
    Department of Biochemistry and Molecular Biology CSMME CNR, University of Bari, Italy
    Exp Mol Pathol 73:28-34. 2002
    ..The putative apo(a) enhancer within LINE1 in the apo(a)-plasminogen intergenic region was investigated for functional polymorphisms. No variants that could be associated to the Lp(a) variability were found...
  9. ncbi The mysteries of lipoprotein(a)
    G Utermann
    Institute for Medical Biology and Genetics, University of Innsbruck, Austria
    Science 246:904-10. 1989
    ..Though of high theoretical and practical interest, many aspects of the metabolism, function, evolution, and regulation of plasma concentrations of Lp(a) are presently unknown, controversial, or mysterious...
  10. ncbi Type of diabetes and waist-hip ratio are important determinants of serum lipoprotein (a) levels in diabetic patients
    Hapizah M Nawawi
    Chemical Pathology Unit, Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Cheras, 56000, Kuala Lumpur, Malaysia
    Diabetes Res Clin Pract 56:221-7. 2002
    ..0001 and P<0.0001, respectively), and were higher in type 1 than type 2 diabetic patients (P<0.05). Waist-hip ratio (WHR) was an independent determinant of Lp(a) concentrations in both type 1 and type 2 diabetes...
  11. ncbi Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin
    Sotirios N Sotiriou
    Experimental Immunology Branch, NCI, NIH, Bethesda, Maryland 20892, USA
    FASEB J 20:559-61. 2006
    ..These observations suggest a novel mechanism for the atherogenic properties of Lp(a)...
  12. ncbi Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women
    M Cubrilo-Turek
    Internal Clinics, General Hospital Sveti Duh, Zagreb, Croatia
    Coll Antropol 22:149-55. 1998
    ..Apolipoprotein E genotypes as genetic markers and investigation of serum metabolic risk markers appear to be important in view for further evaluation of high risk women for CHD in our population...
  13. ncbi Lipoprotein(a) as a marker for coronary heart disease
    P Duriez
    , Institut Pasteur, INSERM U 325, Lille, France
    Br J Clin Pract Suppl 77:54-61. 1996
    ..Although our findings are in agreement with those of a previously published report, there is still a great need to confirm the data that have been reported in separate studies...
  14. ncbi The effects of thyroid status on serum apolipoprotein A-I-containing lipoprotein particles
    M Ozata
    Department of Endocrinology and Metabolism, Gulhane School of Medicine, Etlik, Ankara, Turkey
    Horm Metab Res 30:217-21. 1998
    ..However, little is known about the influence of thyroid hormone on Lp A-I and LpA-I:A-II particles...
  15. ncbi Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia
    U Rosing
    Department of Obstetrics and Gynecology, Karolinska Institutet, Huddinge University Hospital, Sweden
    Horm Metab Res 21:376-82. 1989
    ..The results indicate that from an atherogenic point of view normal pregnancy seems more beneficial than pre-eclampsia...
  16. ncbi Elution of lipoprotein fractions containing apolipoproteins E and A-I in size exclusion on Superose 6 columns is sensitive to mobile phase pH and ionic strength
    J Westerlund
    Lipid and Lipoprotein Research Group, University of Alberta, Edmonton, Canada
    J Chromatogr A 718:59-66. 1995
    ..By density ultracentrifugation, apoE and apoA-I were mostly (> 90%) confined to high-density lipoproteins (HDL, d = 1.063-1...
  17. ncbi Correlation between plasma lipoprotein Lp(a) and sex hormone concentrations: a cross-sectional study in healthy males
    L Denti
    Chair of Gerontology and Geriatrics, University of Parma, Italy
    Horm Metab Res 26:602-8. 1994
    ..on lipid metabolism, mainly on Lp(a), under physiological conditions; population samples homogeneous in terms of apo a isoforms could be the ideal objects of such studies, in order to avoid the great interindividual variability of Lp(..
  18. ncbi Rapid reversed-phase high-performance liquid chromatography method for quantitation, at high pH, of the recombinant apolipoprotein A-IMilano in Escherichia coli fermentation broth
    E Mulugeta
    Pharmacia and Upjohn AB, Process R and D, Stockholm, Sweden
    J Chromatogr A 798:83-90. 1998
    ..With suitable modifications and adaptions this method is likely to be useful for similar rapid analytical determination of recombinant proteins in complex solutions...
  19. ncbi Characterization of lipoprotein a by capillary zone electrophoresis
    A Z Hu
    Department of Chemistry, Texas A and M University, College Station 77843-3255, USA
    J Chromatogr A 717:33-9. 1995
    ..BA molecules associated with Lp(a-) and LDL to enhance their UV absorbance, but did not change their effective electrophoretic mobilities. Our results show that CE is a very efficient and effective technique for lipoprotein analysis...
  20. ncbi Capillary electrophoresis, a rapid and sensitive method for routine analysis of apolipoprotein A-I in clinical samples
    H M Liebich
    Abteilung IV Endokrinologie und Klinische Chemie, , , Germany
    J Chromatogr A 717:25-31. 1995
    ..concentration plot, covering the range of the clinically relevant Apo A-I serum contents, suggest the introduction of this method routinely in clinical laboratories...
  21. ncbi Purification of protein and recycling of polymers in a new aqueous two-phase system using two thermoseparating polymers
    J Persson
    Department of Biochemistry, Lund University, Sweden
    J Chromatogr A 864:31-48. 1999
    ..5) of apolipoprotein A-1 was constant during three polymer recyclings. This new phase system based on two thermoseparating polymers is of great interest in large scale extractions where polymer recycling is of increasing importance...
  22. ncbi Transcriptional regulation of the human apolipoprotein genes
    V I Zannis
    Section of Molecular Genetics, Whitaker Cardiovascular Institute, Departments of Medicine and Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118 239, USA
    Front Biosci 6:D456-504. 2001
    ..Summarized below are the key findings for individual genes and gene clusters. ApoA-II...
  23. ncbi Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II
    A Marzal-Casacuberta
    Department of Cell Biology, Baylor College of Medicine, Houston, Texas, 77030, USA
    J Biol Chem 271:6720-8. 1996
    ..The two major protein components of HDL are apolipoprotein (apo) A-I and apoA-II...
  24. ncbi Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I
    Hongli L Zhu
    Department of Physiology and Biophysics, Boston University School of Medicine, 715 Albany Street, Boston, Massachusetts 02118 2526, USA
    Biochemistry 46:1624-34. 2007
    Human apolipoprotein A-I (apoA-I) is the principle apolipoprotein of high-density lipoproteins that are critically involved in reverse cholesterol transport...
  25. ncbi Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism
    J R Wetterau
    Department of Pharmacology and Cell Biophysics, University of Cincinnati
    Horm Metab Res 24:289-96. 1992
    ..We propose that the increase in lipid transfer activity may in part explain the changes in HDL concentration and size, as well as the previously reported effect probucol has on reducing atherosclerosis in animal models...
  26. ncbi Structural organization of lipid phase and protein-lipid interface in apolipoprotein-phospholipid recombinants: influence of cholesterol
    A D Dergunov
    National Research Centre for Preventive Medicine, Moscow, Russia
    Biochim Biophys Acta 1346:131-46. 1997
    ..15:1. ApoA-I/DPPC/Chol complexes with different protein content (initial DPPC/apoA-I weight ratios were changed from 10...
  27. ncbi Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I
    Hongli L Zhu
    Department of Physiology and Biophysics, Boston University School of Medicine, 715 Albany Street, Boston, Massachusetts 02118, USA
    Biochemistry 43:13156-64. 2004
    ..Residues 1-43 of human apoA-I, encoded by exon 3 of the gene, are highly conserved and less well understood than residues 44-243, encoded by ..
  28. ncbi Mass spectral analyses of the two major apolipoproteins of great ape high density lipoproteins
    Donald L Puppione
    The Molecular Biology Institute, University of California, Los Angeles, CA 90095, USA
    Comp Biochem Physiol Part D Genomics Proteomics 4:305-9. 2009
    ..major apolipoproteins associated with human and chimpanzee (Pan troglodytes) high density lipoproteins (HDL) are apoA-I and dimeric apoA-II...
  29. ncbi Mass spectral analyses of the two major apolipoproteins of great ape high density lipoproteins
    Donald L Puppione
    The Molecular Biology Institute, UCLA, Los Angeles, CA 90095, USA
    Comp Biochem Physiol Part D Genomics Proteomics 4:305-9. 2009
    ..major apolipoproteins associated with human and chimpanzee (Pan troglodytes) high density lipoproteins (HDL) are apoA-I and dimeric apoA-II...
  30. ncbi Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation
    Kerry Anne Rye
    Lipid Research Laboratory, Hanson Institute, Adelaide, South Australia 5000, Australia
    J Biol Chem 278:22530-6. 2003
    ..are classified on the basis of apolipoprotein composition into those containing apolipoprotein (apo) A-I but not apoA-II, (A-I)HDL, and those containing both apoA-I and apoA-II, (A-I/A-II)HDL...
  31. ncbi High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
    G Walldius
    Astra Zeneca, Mölndal and King Gustaf V Research Institute, Karolinska Institute, Stockholm, Sweden
    Lancet 358:2026-33. 2001
    Apolipoprotein B (apoB) and apolipoprotein A-I (apoA-I) are thought to be better predictors of acute myocardial infarction than total cholesterol and LDL-cholesterol...
  32. ncbi Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans
    Byambaa Enkhmaa
    Department of Medicine, University of California, Davis, Sacramento, USA
    Am J Cardiol 106:1264-9. 2010
    Studies have demonstrated that the apolipoprotein B/apolipoprotein A-I (apoB/apoA-I) ratio predicts cardiovascular risk better than any of the cholesterol indexes...
  33. ncbi Efficacy and tolerability of simvastatin 20 mg vs pravastatin 20 mg in patients with primary hypercholesterolemia. European Study Group
    L J Lambrecht
    O L V Aalst, Belgium
    Acta Cardiol 48:541-54. 1993
    ....
  34. ncbi Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism
    Jeffrey S Cohn
    Hyperlipidemia and Atherosclerosis Research Group, Montreal, Quebec, Canada
    J Lipid Res 44:1976-83. 2003
    ..e., apolipoprotein A-I (apoA-I), apoC-I, apoC-III, and apoE], and b) to investigate to what extent these metabolic parameters are related to ..
  35. ncbi Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II
    M A Clay
    The University of Adelaide, Department of Medicine, Royal Adelaide Hospital, Adelaide, South Australia 5000, Australia
    Biochem J 337:445-51. 1999
    We have shown previously that apolipoprotein A (apoA)-I-containing high-density lipoprotein (HDL) particles are formed by the conjugation of lipid-free apoA-I with lipids derived from other lipoprotein fractions in a process dependent on ..
  36. ncbi The satiety factor apolipoprotein A-IV modulates intestinal epithelial permeability through its interaction with alpha-catenin: implications for inflammatory bowel diseases
    E Orso
    Institute for Clinical Chemistry and Laboratory Medicine, University Clinic of Regensburg, Regensburg, and Medical Clinic III, University Hospital Carl Gustav Carus, Dresden, Germany
    Horm Metab Res 39:601-11. 2007
    Apolipoprotein A-IV (apoA-IV), an intestinally and cerebrally synthesized satiety factor and anti-atherogenic plasma apolipoprotein, was recently identified as an anti-inflammatory protein...
  37. ncbi Role of apolipoprotein A-I in protecting against endotoxin toxicity
    Juan Ma
    Department of Biochemistry, School of Pharmacy, Fudan University, Shanghai 200032, China
    Acta Biochim Biophys Sin (Shanghai) 36:419-24. 2004
    ..We investigated the function of Apolipoprotein A-I (ApoA-I), a major apolipoprotein in HDL, in this process...
  38. ncbi Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I
    John K Bielicki
    Genome Sciences Department, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
    Biochemistry 41:2089-96. 2002
    Apolipoprotein A-I(Milano) (apoA-I(Milano)) and apoA-I(Paris) are rare cysteine variants of apoA-I that produce a HDL deficiency in the absence of cardiovascular disease in humans...
  39. ncbi Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects
    Thomas A Hughes
    Health Science Center, Department of Medicine, University of Tennessee, Memphis, TN 38163, USA
    Metabolism 55:26-34. 2006
    ..LDL CE (-13%), phospholipids (-9%), and apolipoprotein (apo) B (-13%); increased HDL-M LpA-I (HDL containing apoA-I without apoA-II, 28%), CE/TG (23%), and CE/apoA-I (8%) while reducing apoA-II (-10%); and increased HDL-L LpA-I (..
  40. ncbi Structure of human apolipoprotein A-IV: a distinct domain architecture among exchangeable apolipoproteins with potential functional implications
    Kevin Pearson
    Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45267, USA
    Biochemistry 43:10719-29. 2004
    Apolipoprotein A-IV (apoA-IV) is an exchangeable apolipoprotein that shares many functional similarities with related apolipoproteins such as apoE and apoA-I but has also been implicated as a circulating satiety factor...
  41. ncbi Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro
    K O
    Department of Pathology, University of British Columbia, Vancouver, Canada
    J Lipid Res 36:2344-54. 1995
    ..The objective of this study was to evaluate the role of LCAT and apolipoprotein A-I (apoA-I) in Lp-X metabolism in vitro and to elucidate the regulation of cholesterol esterification in this unique ..
  42. ncbi Capillary electrophoresis in biochemical and clinical laboratoriesp selected attractive examples
    W Voelter
    , , Germany
    J Chromatogr A 807:135-49. 1998
    ....
  43. ncbi Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol
    Manal Zabalawi
    Department of Pathology, Wake Forest University Health Sciences, Medical Center Boulevard, Winston Salem, NC 27157, USA
    Am J Pathol 163:1201-13. 2003
    ..to dietary fat and cholesterol challenge was evaluated in mice lacking both the LDL receptor (LDLr(-/-)) and apoA-I (apoA-I(-/-)) gene, LDLr(-/-)/apoA-I(-/-) or double-knockout mice...
  44. ncbi Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome
    John S Millar
    Departments of Pharmacology, University of Pennsylvania, 652 BRB II III, 421 Curie Blvd, Philadelphia, PA 19104, USA
    Arterioscler Thromb Vasc Biol 29:140-6. 2009
    The study of PPAR-alpha activation on apoA-I production in humans has been limited to fibrates, relatively weak PPAR-alpha agonists that may have other molecular effects...
  45. ncbi The relationship among apolipoprotein(a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes, and plasma lipoprotein(A) concentration in the Czech population
    Petr Benes
    Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
    Hum Biol 74:129-36. 2002
    ..was designed to investigate the relationship between the K-IV and (TTTTA)n apolipoprotein(a) [apo(a), protein; APOA, gene] polymorphisms, as well as the C766T low-density lipoprotein receptor-related protein (LRP) and the (CGG)n ..
  46. ncbi Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease
    B F Asztalos
    Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, New England Medical Center, 711 Washington Street, Boston, MA 02111, USA
    Atherosclerosis 156:217-25. 2001
    ..In the proband HDL-C, apoA-I, and apoA-II concentrations were 2, 1, and 2 mg/dl, respectively, apoA-I was present only in prebeta(1), while ..
  47. ncbi Lysophosphatidic acid stimulates protein kinase C isoforms alpha, beta, epsilon, and zeta in a pertussis toxin sensitive pathway in vascular smooth muscle cells
    S Seewald
    , Bonn, Germany
    Am J Hypertens 12:532-7. 1999
    The natural phospholipid lysophosphatidic acid (LPA) has been characterized as an important vascular smooth muscle cell (VSMC) mitogen whose effects are mainly mediated by pertussis toxin (PTX)-sensitive guanosine triphosphate (GTP)-..
  48. ncbi Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice
    Uwe J F Tietge
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Arterioscler Thromb Vasc Biol 22:1213-8. 2002
    ..Secretory phospholipase A2 (sPLA2), an acute-phase protein, may play a key role in the pathophysiology of this phenomenon...
  49. ncbi Ascorbic acid and alpha-tocopherol down-regulate apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines
    Arshag D Mooradian
    Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, MO 63104, USA
    Metabolism 55:159-67. 2006
    ..antioxidants to study some of the molecular pathways underlying antioxidant-related changes in apolipoprotein A-I (apoA-I) expression...
  50. ncbi The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis
    Murat Celiloglu
    Departments of 1Obstetrics and Gynecology and 2Radiology, Dokuz Eylul University Medical Faculty, Izmir, Turkey
    Menopause 16:689-93. 2009
    ..used in the treatment of osteoporosis, on carotid artery intima-media thickness (IMT), the lipid profile, and apolipoprotein A-I (ApoA-I) and apolipoprotein B (ApoB) levels, which are known to have a role in the atherosclerotic process.
  51. ncbi Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential
    Vicent Ribas
    Institut de Recerca de l Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Circ Res 95:789-97. 2004
    Apolipoprotein A-II (apoA-II), the second major high-density lipoprotein (HDL) apolipoprotein, has been linked to familial combined hyperlipidemia. Human apoA-II transgenic mice constitute an animal model for this proatherogenic disease...
  52. ncbi Regulation of human apolipoprotein A-I gene expression by equine estrogens
    X Zhang
    Department of Biochemistry, Queen s University, Kingston, Ontario, Canada
    J Lipid Res 42:1789-800. 2001
    ..stable cell line (HepG2/S) that harbors a luciferase reporter gene cassette with the human apolipoprotein A-I (apoA-I) promoter region was used to examine the activity of CEE components in modulating human apoA-I promoter activity...
  53. ncbi GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex
    M A Deeg
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Lipid Res 42:442-51. 2001
    ..Apolipoprotein (apo)-specific lipoproteins containing apoB (Lp[B]), apoA-I and A-II (Lp[A-I, A-II]), or apoA-I only (Lp[A-I]) were isolated using dextran sulfate and immunoaffinity ..
  54. ncbi Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease
    D J Rader
    Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892
    J Clin Invest 93:321-30. 1994
    ..We investigated the metabolism of the HDL apolipoproteins (apo) apoA-I and apoA-II in a total of five patients with LCAT deficiency, one with classic LCAT deficiency and four with Fish-..
  55. ncbi Apolipoprotein A-II is inversely associated with risk of future coronary artery disease
    Rakesh S Birjmohun
    Academic Medical Center, Department of Vascular Medicine, 1100 DD, Amsterdam, The Netherlands
    Circulation 116:2029-35. 2007
    Although the vasculoprotective effects of apolipoprotein A-I (apoA-I), the major protein associated with high-density lipoprotein, have been universally accepted, apoA-II has been suggested to have poor antiatherogenic or even ..
  56. ncbi Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial
    Steven E Nissen
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    JAMA 290:2292-300. 2003
    ..b>ApoA-I Milano is a variant of apolipoprotein A-I identified in individuals in rural Italy who exhibit very low levels of ..
  57. ncbi Transformation of large discoidal complexes of apolipoprotein A-I and phosphatidylcholine by lecithin-cholesterol acyltransferase
    E L Gong
    Lawrence Berkeley Laboratory, University of California, Berkeley 94720
    Biochim Biophys Acta 961:73-85. 1988
    ..The deformable species observed during transformation were similar in size and shape to particles observed in interstitial fluid...
  58. ncbi Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism
    R A Srivastava
    Division of Atherosclerosis, Nutrition and Lipid Research, Department of Internal Medicine, Washington University, St Louis, MO, USA
    Eur J Biochem 267:4272-80. 2000
    ..Nontransgenic (NTg) C57BL mice and apoA-I-transgenic (apoAI-Tg) mice, with greatly increased basal apoA-I and HDL levels, were used...
  59. ncbi Age-associated decreases in the messenger ribonucleic acid level and the rate of synthesis of apolipoprotein A-II in murine senile amyloidosis
    K Kitagawa
    Department of Senescence Biology, Kyoto University, Japan
    Lab Invest 70:565-71. 1994
    Apolipoprotein A-II (apoA-II), an apoprotein of serum high density lipoprotein, is the serum precursor of murine senile amyloid protein fibril...
  60. ncbi The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation
    M G Sorci-Thomas
    Department of Pathology and Comparative Medicine, Wake Forest University School of Medicine, Winston Salen, North Carolina 27157, USA
    J Biol Chem 273:11776-82. 1998
    Apolipoprotein A-I (apoA-I) activates the plasma enzyme lecithin:cholesterol acyltransferase (LCAT), catalyzing the rapid conversion of lipoprotein cholesterol to cholesterol ester...
  61. ncbi Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis
    Houssein Hajj Hassan
    Cardiovascular Genetics Laboratory, Cardiology Division, McGill University Health Centre Royal Victoria Hospital, Montreal, Quebec, Canada
    J Lipid Res 48:2428-42. 2007
    It is well accepted that both apolipoprotein A-I (apoA-I) and ABCA1 play crucial roles in HDL biogenesis and in the human atheroprotective system. However, the nature and specifics of apoA-I/ABCA1 interactions remain poorly understood...
  62. ncbi Assignment of the binding site for haptoglobin on apolipoprotein A-I
    Maria Stefania Spagnuolo
    Dipartimento di Fisiologia Generale ed Ambientale, Universita di Napoli Federico II, Via Mezzocannone 8, 80134 Napoli, Italia
    J Biol Chem 280:1193-8. 2005
    Haptoglobin (Hpt) was previously found to bind the high density lipoprotein (HDL) apolipoprotein A-I (ApoA-I) and able to inhibit the ApoA-I-dependent activity of the enzyme lecithin:cholesterol acyltransferase (LCAT), which plays a major ..
  63. ncbi Clearance of cationized LDL cholesterol from a muscle depot is not enhanced in human apolipoprotein A-IV transgenic mice
    Y Stein
    Lipid Research Laboratory, Division of Medicine, Hadassah University Hospital, Jerusalem, Israel
    Arterioscler Thromb Vasc Biol 20:179-84. 2000
    Human apolipoprotein A-IV (apoA-IV) transgenic mice fed an atherogenic diet were shown previously to develop less atherosclerosis than control mice...
  64. ncbi [Influence of a G/A substitution at -75 bp promoter region of apolipoprotein A I gene and wine consumption on the plasma apolipoprotein A I levels in Yi and Han Chinese]
    Q Zhao
    Department of Pathology, Institute of Basic Medical Sciences, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, China
    Zhonghua Bing Li Xue Za Zhi 29:343-6. 2000
    To study the influence of a common polymorphism of the human apolipoprotein A I gene promoter at a position of -75 bp upstream of the transcription start site and wine consumption on plasma lipid levels.
  65. ncbi Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding
    A Minnich
    Department of Medicine, Boston University School of Medicine, Massachusetts 02118
    J Biol Chem 267:16553-60. 1992
    We have mutagenized the human apoA-I gene and have generated cell lines which express normal and mutant apoA-I forms. Point mutations were introduced which changed Gln-1, Gln-2 to Arg,Arg, Pro99 to His, and Pro121 to His...
  66. ncbi Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro
    G M Rayan
    Department of Orthopaedic Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, USA
    J Hand Surg Am 21:1065-70. 1996
    ..In the first part of the study, lysophosphatidic acid (LPA), serotonin, angiotensin II, and prostaglandin F2 alpha were tested for their ability to promote Dupuytren's ..
  67. ncbi Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover
    D L Silver
    Division of Molecular Medicine, Department of Medicine, Columbia University, New York, New York 10032, USA
    J Biol Chem 274:4140-6. 1999
    ..plasma high density lipoprotein (HDL) levels commonly reflect altered metabolism of the major HDL apolipoproteins, apoA-I and apoA-II, but the regulation of apolipoprotein metabolism is poorly understood...
  68. ncbi The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways
    Robert S Kiss
    Lipoprotein and Atherosclerosis Research Group, Department of Pathology and Laboratory Medicine, University of Ottawa Heart Institute, Ontario K1Y 4W7, Canada
    J Biol Chem 278:10119-27. 2003
    The pathways of hepatic intra- and peri-cellular lipidation of apolipoprotein A-I (apoA-I) were studied by infecting primary mouse hepatocytes from either apoA-I-deficient or ABCA1-deficient mice with a recombinant adenovirus expressing ..
  69. ncbi [Hyperlipoprotein (a)-emia determined by genetic polymorphisms in apolipoprotein (a) gene]
    Akitada Ichinose
    Department of Molecular Patho Biochemistry and Patho Biology on Blood and Circulation, Yamagata University School of Medicine, 2 2 2 lIida nishi, Yamagata 990 9585, Japan
    Brain Nerve 60:1307-17. 2008
    ..e., number of kringle-4 repeats in the gene) of apolipoprotein (a) are risk factors for the development of atherothrombosis...
  70. ncbi The interfacial properties of ApoA-I and an amphipathic alpha-helix consensus peptide of exchangeable apolipoproteins at the triolein/water interface
    Libo Wang
    Department of Physiology and Biophysics, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Biol Chem 280:4154-65. 2005
    Apolipoprotein A-I (apoA-I) is the major protein in high density lipoprotein (HDL). During lipid metabolism, apoA-I moves among HDL and triacylglycerol-rich lipoproteins...
  71. ncbi Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I
    Yuan Qi Wong
    Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia
    Proc Natl Acad Sci U S A 107:1977-82. 2010
    Apolipoprotein A-I (apoA-I) is the major protein component of HDL, where it plays an important role in cholesterol transport...
  72. ncbi Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease
    A D Sniderman
    Mike Rosenbloom Laboratory for Cardiovascular Research, Royal Victoria Hospital, Montreal, Quebec, Canada
    J Intern Med 259:455-61. 2006
    ..to demonstrate the frequency and extent of error that results from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to estimate the lipoprotein-related risk of vascular disease within 94,667 men and 75,675 women in the ..
  73. ncbi In vivo metabolism of proapolipoprotein A-I in Tangier disease
    D Bojanovski
    Molecular Disease Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892
    J Clin Invest 80:1742-7. 1987
    Tangier disease is a rare familial disorder characterized by extremely low levels of apolipoprotein A-I (apoA-I) and high density lipoproteins (HDL)...
  74. ncbi Comparison of high-density lipoprotein cholesterol to apolipoprotein A-I and A-II to predict coronary calcium and the effect of insulin resistance
    Seth S Martin
    Cardiovascular Institute, University of Pennsylvania Medical Center, Philadelphia, USA
    Am J Cardiol 107:393-8. 2011
    ..confound the association of HDL cholesterol with coronary artery calcification (CAC) and that apolipoprotein A-I (apoA-I) and/or apolipoprotein A-II (apoA-II) would add to HDL cholesterol in predicting CAC...
  75. ncbi Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB/iNOS
    Leonie G Mikael
    Department of Human Genetics, McGill University, Montreal Children s Hospital Research Institute, 4060 Ste Catherine West, Suite 241, Montreal, Quebec, Canada H3Z 2Z3
    Cardiovasc Res 80:151-8. 2008
    ..In earlier work, we showed that homocysteine (Hcy) reduced synthesis of apolipoprotein A-I (ApoA-I)...
  76. ncbi Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study
    G Walldius
    King Gustaf V Research Institute, Karolinska Institute, Stockholm, Sweden
    J Intern Med 259:259-66. 2006
    ..main objective of the present study was to determine if the risk of stroke is related to the balance between the proatherogenic apoB lipoprotein particles and the antiatherogenic apoA-I particles as is the case for myocardial infarction.
  77. ncbi Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice
    R A Srivastava
    Division of Atherosclerosis, Nutrition and Lipid Research, Washington University School of Medicine, Saint Louis, MO, USA
    Mol Cell Biochem 209:125-9. 2000
    ..protein involved in mammalian cholesterol transport, were found to be 2-3 fold lower in mice over-expressing human apoA-I gene...
  78. ncbi Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice
    G Franceschini
    Center E Grossi Paoletti and Institute of Pharmacological Sciences, University of Milano, Italy
    Arterioscler Thromb Vasc Biol 19:1257-62. 1999
    ..Carriers of the ApoA-IMilano (A-IM) mutant have a severe hypoalphalipoproteinemia but are not at increased risk for premature of ..
  79. ncbi Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase
    Alfonso Salvatore
    Dipartimento delle Scienze Biologiche, Universita di Napoli Federico II, Via Mezzocannone 8, 80134 Napoli, Italy
    Biochemistry 46:11158-68. 2007
    Apolipoprotein A-I (ApoA-I), a major component of HDL, binds haptoglobin, a plasma protein transporting to liver or macrophages free Hb for preventing hydroxyl radical production...
  80. ncbi Effect of glycerol-induced DNA conformational change on the separation of DNA fragments by capillary electrophoresis
    D Liang
    Department of Chemistry, State University of New York at Stony Brook, 11794-3400, USA
    J Chromatogr A 931:163-73. 2001
    The effect on DNA separation of adding glycerol to the running buffer was studied using linear polyacrylamide (LPA) or poly(ethylene oxide) (PEO) as separation medium...
  81. ncbi PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor
    H Takeda
    Second Department of Internal Medicine, Kobe University School of Medicine, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
    EMBO J 18:386-95. 1999
    Receptors coupled to the inhibitory G protein Gi, such as that for lysophosphatidic acid (LPA), have been shown to activate MAP kinase through a RAS-dependent pathway...
  82. ncbi EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16
    H Okamoto
    Department of Physiology, Kanazawa University School of Medicine, 13 1 Takara machi, Kanazawa, 920 8640, Japan
    Biochem Biophys Res Commun 260:203-8. 1999
    ..EDG1 are functional receptors for lysosphingolipids, whereas EDG2 and EGD4 are receptors for lysophosphatidic acid (LPA)...
  83. ncbi Separation of DNA fragments by capillary electrophoresis using replaceable linear polyacrylamide matrices
    Y F Pariat
    Barnett Institute, Northeastern University, Boston, MA 02115
    J Chromatogr A 652:57-66. 1993
    The use of low percent (1.5-6% T) replaceable linear polyacrylamide (LPA) network matrices for rapid separation of double-stranded DNA fragments was explored...
  84. ncbi apoB/apoA-I ratio is related to femoral artery plaques and is predictive for future cardiovascular events in healthy men
    C Schmidt
    The Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Academy at Goteborg University, Gothenburg, Sweden
    Atherosclerosis 189:178-85. 2006
    The aim of the present study was to investigate the association between serum concentrations of apoB, apoA-I and the apoB/apoA-I ratio and future cardiovascular events in a group of healthy 58-year-old men during 6.6 years of follow-up...
  85. ncbi Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer
    Hans Dieplinger
    Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, A 6020 Innsbruck, Austria
    Cancer Epidemiol Biomarkers Prev 18:1127-33. 2009
    ..In addition, we observed in a previous small study decreased plasma concentrations of apolipoprotein A-IV (apoA-IV) in preoperative patients with kidney cancer...
  86. ncbi Activity of peroxisomal enzymes, and levels of polyamines in LPA-transgenic mice on two different diets
    Knut A Eliassen
    Department Basic Sciences and Aquatic Medicine, Norwegian School of Veterinary Science, PO Box 8146, Dep No 0033 Oslo, Norway
    Lipids Health Dis 4:23. 2005
    ..It was therefore of interest to examine polyamines and their metabolism in LPA transgenic mice...
  87. ncbi LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial
    Bela F Asztalos
    Lipid Metabolism Laboratory, JM USDA HNRCA, Tufts University, 711 Washington Street, Boston, MA 02111, USA
    Atherosclerosis 188:59-67. 2006
    We tested the hypothesis that concentrations of LpA-I and/or LpA-I:A-II HDL subclasses are significantly associated with CHD prevalence and recurrent cardiovascular events.
  88. ncbi The apo(a) gene (TTTTA)n promoter polymorphism and its association with variability in exons of the kringle IV types 8 to 10
    Katerina Hirschfeldova
    Institute of Biology and Medical Genetics, 1st Faculty of Medicine and General Teaching Hospital in Prague, Charles University, Prague, 12800, Czech Republic
    Clin Chim Acta 405:39-42. 2009
    ..The (TTTTA)(n) repetition from the promoter of the apo(a) gene is supposed to be a relevant candidate for the additional regulation of lipoprotein (a) levels...
  89. ncbi Apolipoprotein(a) gene polymorphisms (TTTTA)n and G/A-914 affect Lp(a) levels in ischemic heart disease patients from Serbia
    Dragan Dincić
    Clinic for Urgent Internal Medicine, Military Medical Academy, Belgrade, Serbia and Montenegro
    Wien Klin Wochenschr 117:406-11. 2005
    ..The pentanucleotide (TTTTA)n repeat and G/A-914 polymorphisms are in the 5' promoter region of the apo(a) gene. To elucidate whether these polymorphisms affect Lp(a) levels, a total of 211 Serbian adults were investigated...
  90. ncbi Apolipoprotein A-I and the molecular variant apoA-I(Milano): evaluation of the antiatherogenic effects in knock-in mouse model
    Cinzia Parolini
    Department of Pharmacological Sciences, University of Milan, 20133 Milan, Italy
    Atherosclerosis 183:222-9. 2005
    No evidence of premature vascular disease is found in apolipoprotein A-I(Milano) (apoA-I(M)) human carriers, despite very low high density lipoprotein (HDL) cholesterol levels...
  91. ncbi Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin
    A L Khandoga
    Institute for Prevention of Cardiovascular Diseases, University of Munich, Munich, Germany
    Platelets 19:415-27. 2008
    Lysophosphatidic acid (LPA), a component of mildly-oxidized LDL and the lipid rich core of atherosclerotic plaques, elicits platelet activation...
  92. ncbi Molecular characterization of native and recombinant apolipoprotein A-IMilano dimer. The introduction of an interchain disulfide bridge remarkably alters the physicochemical properties of apolipoprotein A-I
    L Calabresi
    Center E Grossi Paoletti, Institute of Pharmacological Sciences, University of Milano, Italy
    J Biol Chem 269:32168-74. 1994
    The disulfide-linked dimer of apolipoprotein A-IMilano (A-IM/A-IM), a natural Arg173-->Cys variant of apoA-I, was purified from carriers' plasma and produced in Escherichia coli...
  93. ncbi Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-kappaB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome
    Shee Uan Chen
    Department of Obstetrics and Gynecology, National Taiwan University Hospital, No 7 Chung Shan South Road, Taipei, Taiwan
    J Clin Endocrinol Metab 93:935-43. 2008
    Lysophosphatidic acid (LPA) was found at significant amounts in follicular fluid of preovulatory follicle. The lysophospholipase D activity of serum from women receiving ovarian stimulation was higher than women with natural cycles...
  94. ncbi Fish intake and LPA 93C>T polymorphism: gene-environment interaction in modulating lipoprotein (a) concentrations
    Francesco Sofi
    Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, Italy
    Atherosclerosis 195:e147-54. 2007
    ..The aim of the study was to evaluate the possible modulation of two polymorphisms of LPA gene (LPA 93C>T and LPA 121G>A) and nutritional habits on Lp(a) concentrations...
  95. ncbi In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism
    K Ikewaki
    Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892
    J Lipid Res 35:1809-19. 1994
    ..Apolipoproteins A-I and E are two of the major apolipoproteins in HDL. Plasma apoA-I levels, but not apoE levels, have been reported to be decreased in patients with ABL...
  96. ncbi Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells
    Pascale M Ohnsorg
    University Hospital, Zurich, Switzerland
    Biochim Biophys Acta 1811:1115-23. 2011
    Apolipoprotein A-I (apoA-I) exerts many potentially anti-atherogenic properties and is therefore attractive for prevention and therapy of coronary heart disease...
  97. ncbi Dioleoyl phosphatidic acid increases intracellular Ca2+ through endogenous LPA receptors in C6 glioma and L2071 fibroblasts
    Young Ja Chang
    Laboratory of Pharmacology, College of Pharmacy and Research Institute for Drug Development, Pusan National University, San 30, Jang Jun dong, Geum Jung gu, Busan 609 735, Republic of Korea
    Prostaglandins Other Lipid Mediat 83:268-76. 2007
    ..Lysophosphatidic acid (LPA) also increased the [Ca(2+)](i) in the both cells...
  98. ncbi Variability in apo(a) gene regulatory sequences, compound genotypes, and association with Lp(a) plasma levels
    Katerina Zidkova
    3rd Medical Department, 1st Faculty of Medicine and General Teaching Hospital, Charles University, Prague, Czech Republic
    Clin Biochem 40:802-5. 2007
    ..Lipoprotein(a) is an independent risk factor of atherosclerosis...
  99. ncbi Analysis of polymorphisms in the 5'-flanking region of the apolipoprotein(a) [Apo(a)] gene in Thai subjects with coronary artery diseases
    Nednapis Tirawanchai
    Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
    J Med Assoc Thai 91:86-92. 2008
    ..Additionally in CAD patients with [Lp(a)] > 30 mg/dL, the genotype frequencies were 60.6, 11.7, 21.3 and 6.4% for types A, B, C and D, respectively. The present study might shed some light to understand CAD at the molecular level...

Research Grants91

  1. Apolipoprotein-mediated cholesterol efflux
    W Davidson; Fiscal Year: 2007
    ..a critical cell surface protein required for the transfer of cellular lipid and cholesterol to lipid-free forms of apoA-I...
  2. Apo E mimetics reduce cholesterol and improve HDL function
    G M Anantharamaiah; Fiscal Year: 2010
    ..Recent advances in apoA-I mimetic peptides indicate the possibility of improving HDL functions...
  3. Structure of apolipoprotein A-I on defined states of HDL
    MICHAEL NOBUAKI ODA; Fiscal Year: 2010
    ..to RCT is the binding and sequestration of lipid by the primary protein component of HDL, apolipoproteinA-I (apoA-I), which, like other exchangeable apolipoproteins, associates with lipid by modulating the exposure of its ..
  4. Asthma Increases Vaso-occlusion in Sickle Cell Disease
    KIRKWOOD A contact PRITCHARD; Fiscal Year: 2010
    ..pulmonary inflammation comes from histology and airway response studies in mice lacking apolipoprotein A-I (apoA-I), the major anti- inflammatory apolipoprotein in HDL...
  5. Dynamics of LCAT activation and lipoprotein remodeling
    Jere P Segrest; Fiscal Year: 2011
    ..combination of direct experimental methods and computer simulations to understand the role of apolipoprotein A-I (apoA-I) dynamics in two important biological functions of HDL: i) activation of the enzyme lecithin:cholesterol acyl ..
  6. HIGH DENSITY LIPOROTEIN STRUCTURE-FUNCTION CORRELATIONS
    Ana Jonas; Fiscal Year: 2001
    ..These functions of HDL, mediated by its major protein component, apolipoprotein A-I (apoA-I), underlie the antiatherogenic role of this lipoprotein class...
  7. SR-BI: INFLUENCE OF APOA-II
    DENEYS VAN DER WESTHUYZEN; Fiscal Year: 2003
    DESCRIPTION: (Adapted from the Investigator's Abstract):HDL and apoA-I plasma levels are inversely related to coronary artery disease...
  8. Atherogenic Effects of Tyrosine Oxidation in HDL
    John Oram; Fiscal Year: 2004
    The interaction of HDL apolipoproteins, particularly apoA-I, with the cell membrane transporter ABCA1 removes excess cellular cholesterol and protects against atherogenesis...
  9. Apolipoprotein A-I structure in high density lipoproteins
    W Davidson; Fiscal Year: 2007
    ..obstacle in the way of a detailed understanding of these effects is the lack of information on the structure of apoA-l in HDL particles that exist in human plasma...
  10. Apolipoprotein A-I structure in high density lipoproteins
    W Sean Davidson; Fiscal Year: 2010
    ..obstacle in the way of a detailed understanding of these effects is the lack of information on the structure of apoA-l in HDL particles that exist in human plasma...
  11. HDL Modulation of monocyte function in endotoxemia
    Geeta Datta; Fiscal Year: 2009
    ..from our laboratory show that a novel 18-residue peptide (4F), whose design is based on the structural features of apoA-I converts HDL from a dysfunctional to functional HDL form...
  12. HDL Modulation of monocyte function in endotoxemia
    Geeta Datta; Fiscal Year: 2009
    ..from our laboratory show that a novel 18-residue peptide (4F), whose design is based on the structural features of apoA-I converts HDL from a dysfunctional to functional HDL form...
  13. HDL Modulation of monocyte function in endotoxemia
    C Roger White; Fiscal Year: 2010
    ..from our laboratory show that a novel 18-residue peptide (4F), whose design is based on the structural features of apoA-I converts HDL from a dysfunctional to functional HDL form...
  14. ApoB and ApoA-I Kinetics in the ApoB-67 Mutation
    Francine Welty; Fiscal Year: 2006
    ..The applicant now proposes to determine mechanisms for the low levels of apoB48 and high levels of HDL-C and apoA-I...
  15. Macrophage Foam Cells, Cathepsins and Cholesterol Efflux
    ALAN RICHARD TALL; Fiscal Year: 2010
    ..The ATP binding cassette transporter ABCA1 mediates cholesterol efflux from macrophage foam cells to apoA-1...
  16. Macrophage Foam Cells, Cathepsins and Cholesterol Efflux
    Alan Tall; Fiscal Year: 2007
    ..The ATP binding cassette transporter ABCA1 mediates cholesterol efflux from macrophage foam cells to apoA-1...
  17. ATHEROSCLEROSIS PREVENTION IN MICE BY MUTANT APO A-1
    GODFREY GETZ; Fiscal Year: 2001
    ..b>ApoA-I(Milano) appears to be an exception to the generalization in that modest levels of HDL in these subjects are ..
  18. High Density Lipoprotein Metabolism Influence of Extracellular Phospholipases
    Daniel Rader; Fiscal Year: 2007
    Plasma levels of high-density lipoprotein (HDL) cholesterol and its major HDL apolipoprotein, apoA-I, are inversely associated with atherosclerotic cardiovascular disease...
  19. CHOLESTEROL METABOLISM--ROLE OF APOA I
    David Williams; Fiscal Year: 2001
    ..The first finding is that steroidogenic tissues of apoA-I-deficient mice show an almost complete failure to accumulate cholesteryl ester, suggesting the hypothesis that ..
  20. Structure-function relations in apoA-I's central domain
    MICHAEL ODA; Fiscal Year: 2007
    ..LCAT activity is dependent on interaction with the primary protein component of HDL, apolipoprotein A-I (apoA-I), which, like other exchangeable apolipoproteins, associates with lipid by modulating the exposure of its ..
  21. Apolipoprotein A-V: A Functional Proteomics Study
    ROBERT O apos MARA RYAN; Fiscal Year: 2010
    ..are known to modulate plasma TG levels, accumulating evidence suggests the recently discovered apolipoprotein A-V (apoA-V) functions in lipid transport and maintenance of plasma TG homeostasis...
  22. APOLIPOPROTEIN VARIATION AND HUMAN DISEASE
    Vassilis Zannis; Fiscal Year: 1999
    ..the last 3 years we have made strides in understanding the complex organization of 5 apolipoprotein promoters (apoA-I, apoCIII, apoA-IV, apoA-II & apoB) and several of the factors which are involved in the regulation of the ..
  23. CHOLECYSTOKININ--ROLE IN POSTPRANDIAL GASTRIC MOTILITY
    Helen Raybould; Fiscal Year: 2003
    ..is dependent on absorption of lipid by enterocytes, formation and release of chylomicrons and apolipoprotein A-IV (apoA-IV), release of CCK. by apo A-IV and CCK acting on CCK-ARs on intestinal afferent nerve terminals...
  24. APOLIPOPROTEIN VARIATION AND HUMAN DISEASE
    Vassilis Zannis; Fiscal Year: 1993
    ..To understand this regulation we propose to identify the factors which bind to three apolipoprotein promoters (apoA-I, apoCIII, and apoA-II), to purify and clone unique factors, and to study in detail the mechanism of ..
  25. The Role of Apolipoprotein A-II in the Modulation of HDL Function
    RANASINGHE SILVA; Fiscal Year: 2007
    ..Studies on apoA-ll have led to mixed conclusions concerning the pro- or antiatherogenicity of apoA-ll in HDL...
  26. HIGH DENSITY LIPOPROTEIN SUBSPECIES AND CORONARY DISEASE
    Bela Asztalos; Fiscal Year: 2003
    ..Within HDL are particles containing apo A-I with apo A-II (LpA-I/A-II) and without apo A-II (LpA-I)...
  27. Apolipoprotein A-V: A Functional Proteomics Study
    Robert Ryan; Fiscal Year: 2007
    ..sequences led to the discovery of a new member of the exchangeable apolipoprotein family, apolipoprotein A-V (apoA-V)...
  28. HDL Dysfunction and Vascular Inflammation
    Kirkwood A Pritchard; Fiscal Year: 2010
    ..Recent reports from this laboratory demonstrate that an apoA-l mimetic, 4F, dramatically improves endothelium-and eNOS-dependent vasodilation in two distinct murine models of ..
  29. Molecular and Funcitonal Analysis of Human A-I
    Vassilis I Zannis; Fiscal Year: 2010
    b>ApoA-I is the major protein component of HDL that is required both for the biogenesis and the functions of HDL. ApoA-I also contributes to the overall lipid homeostasis in the circulation and to atheroprotection...